Artivion | CRY - Betriebsergebnis





Betriebsergebnis Veränderung Datum
Abbott USD 2.13B 281M 2026-06
Accuray USD 4.71M 6.86M 2024-12
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 9.66M 9.14M 2026-06
Baxter International USD 276M 210M 2026-06
Becton, Dickinson and Co. USD 627M 36M 2026-03
Boston Scientific USD 1.24B 190M 2026-06
Edwards Lifesciences USD 519.5M 4.8M 2026-06
Inogen USD -7.79M 728K 2024-09
Integra LifeSciences USD 41.29M 29.82M 2026-06
J&J USD 7.48B 860M 2026-06
Mesa Laboratories USD 5.78M 2.27M 2024-12
Orthofix International USD 6.12M 1.91M 2025-12
Pfizer USD 4.99B 340M 2026-03
ResMed USD 505.67M 8.07M 2026-03
Stryker USD 1.79B 687M 2026-06
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 37.03M 686K 2026-03
Terumo JPY 31.45B 12.43B 2026-03
Trinity Biotech USD -1.3M 796K 2025-12